Safety and tolerability of nintedanib for the treatment of idiopathic pulmonary fibrosis in routine UK clinical practice

In IPF, commencement of antifibrotic therapy in patients with preserved lung volume may increase the duration of therapy http://ow.ly/4HeM30lFS67

Na minha lista:
Detalhes bibliográficos
Publicado no:ERJ Open Res
Main Authors: Fletcher, Sophie V., Jones, Mark G., Renzoni, Elizabeth A., Parfrey, Helen, Hoyles, Rachel K., Spinks, Katherine, Kokosi, Maria, Kwok, Apollinaris, Warburton, Chris, Titmuss, Vanessa, Thillai, Muhunthan, Simler, Nicola, Maher, Toby M., Brereton, Christopher J., Chua, Felix, Wells, Athol U., Richeldi, Luca, Spencer, Lisa G.
Formato: Artigo
Idioma:Inglês
Publicado em: European Respiratory Society 2018
Assuntos:
Original Research Letters
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6194204/
https://ncbi.nlm.nih.gov/pubmed/30364342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00049-2018
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados